Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials01:16

Clinical Trials

10.7K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.7K
Clinical Trials: Overview01:11

Clinical Trials: Overview

5.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.0K
Types of Hypothesis Testing01:11

Types of Hypothesis Testing

27.9K
There are three types of hypothesis tests: right-tailed, left-tailed, and two-tailed.
When the null and alternative hypotheses are stated, it is observed that the null hypothesis is a neutral statement against which the alternative hypothesis is tested. The alternative hypothesis is a claim that instead has a certain direction. If the null hypothesis claims that p = 0.5, the alternative hypothesis would be an opposing statement to this and can be put either p > 0.5, p < 0.5, or p...
27.9K
Errors In Hypothesis Tests01:14

Errors In Hypothesis Tests

6.0K
When performing a hypothesis test, there are four possible outcomes depending on the actual truth (or falseness) of the null hypothesis and the decision to reject or not.
6.0K
Statistical Hypothesis Testing01:16

Statistical Hypothesis Testing

7.0K
Hypothesis testing is a critical statistical procedure facilitating informed, evidence-based decisions. It begins with a hypothesis, which is a tentative explanation, or a prediction about a population parameter. This hypothesis can be either a null hypothesis (H0), indicating no effect or difference, or an alternative hypothesis (Ha), suggesting an effect or difference.
Statistical significance measures the probability that an observed result occurred by chance. If this probability, known as...
7.0K
Accuracy and Errors in Hypothesis Testing01:13

Accuracy and Errors in Hypothesis Testing

599
Hypothesis testing is a fundamental statistical tool that begins with the assumption that the null hypothesis H0 is true. During this process, two types of errors can occur: Type I and Type II. A Type I error refers to the incorrect rejection of a true null hypothesis, while a Type II error involves the failure to reject a false null hypothesis.
In hypothesis testing, the probability of making a Type I error, denoted as α, is commonly set at 0.05. This significance level indicates a 5%...
599

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reduced conversion and readmission rates in robotic ileocecal resection for Crohn's disease: a propensity-matched analysis of the Hugo™ RAS system.

Surgical endoscopy·2026
Same author

Reliable classification of polyps based on artificial intelligence: a development and validation study.

EClinicalMedicine·2026
Same author

Age disparity in robotic colorectal surgery: overcoming surgeon hesitancy to improve elderly patient outcomes.

Journal of robotic surgery·2026
Same author

Applicability of mitotic figure counting by deep learning: a development and pan-cancer validation study.

FEBS open bio·2026
Same author

Negative Selection Maintains Grossly Altered but Broadly Stable Karyotypes in Metastatic Colorectal Cancer.

Cancer discovery·2026
Same author

Surgical management of small bowel adenocarcinoma in Crohn disease: a multicenter retrospective analysis.

Inflammatory bowel diseases·2025

Related Experiment Video

Updated: Feb 5, 2026

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.3K

Optimal designs for testing hypothesis in multiarm clinical trials.

Alessandro Baldi Antognini1, Marco Novelli1, Maroussa Zagoraiou1

  • 1Department of Statistical Sciences, University of Bologna, Bologna, Italy.

Statistical Methods in Medical Research
|September 21, 2018
PubMed
Summary

This study introduces a new design for randomized clinical trials that balances statistical accuracy with patient welfare. The proposed method optimizes treatment allocation to increase the power of statistical tests while considering treatment effectiveness.

Keywords:
Asymptotic inferenceWald testethicspowerresponse-adaptive designs

More Related Videos

Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay
14:45

Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay

Published on: September 16, 2012

15.5K
Morris Water Maze Test: Optimization for Mouse Strain and Testing Environment
10:24

Morris Water Maze Test: Optimization for Mouse Strain and Testing Environment

Published on: June 22, 2015

22.5K

Related Experiment Videos

Last Updated: Feb 5, 2026

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.3K
Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay
14:45

Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay

Published on: September 16, 2012

15.5K
Morris Water Maze Test: Optimization for Mouse Strain and Testing Environment
10:24

Morris Water Maze Test: Optimization for Mouse Strain and Testing Environment

Published on: June 22, 2015

22.5K

Area of Science:

  • Biostatistics
  • Clinical Trial Design
  • Medical Research Methodology

Background:

  • Traditional clinical trial designs often prioritize statistical power over ethical considerations.
  • Existing literature primarily focuses on treatment effect estimation, particularly for binary outcomes in two-treatment scenarios.
  • There is a need for methods that integrate ethical concerns into the design of multiarm clinical trials.

Purpose of the Study:

  • To develop a randomized multiarm clinical trial design that optimizes the trade-off between inferential precision and ethical concerns.
  • To maximize the power of statistical tests for detecting treatment effects in normally distributed response trials.
  • To propose a design methodology that incorporates ethical constraints reflecting treatment effectiveness.

Main Methods:

  • The study discusses allocation strategies that optimize the power of the classical multivariate test of homogeneity.
  • A multipurpose design methodology based on constrained optimization is proposed.
  • The methodology aims to maximize statistical test power under ethical constraints related to treatment effectiveness.

Main Results:

  • The proposed constrained optimal allocation is a non-degenerate continuous function of treatment contrasts.
  • This allocation can be approximated using standard response-adaptive randomization procedures.
  • The method demonstrates good performance in terms of both ethical gain and statistical efficiency, including estimation precision.

Conclusions:

  • The developed constrained optimization approach provides an effective method for designing randomized clinical trials.
  • This methodology successfully balances statistical power with ethical considerations in treatment comparisons.
  • The approach is suitable for normally response trials and can be implemented using adaptive randomization techniques.